Turn Therapeutics Inc. - Form 8-K Summary
Business Context and Reporting Period
Turn Therapeutics Inc. (TTRX), a Delaware corporation and emerging growth company, filed this Current Report on Form 8-K on February 17, 2026. The filing serves to disclose a press release issued on the same date under Item 7.01 (Regulation FD Disclosure).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to announce a press release and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes versus prior periods are detailed in this specific filing text. The document references an attached press release (Exhibit 99.1) for the substantive announcement but does not summarize its content within the body of the 8-K.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors. It explicitly states that the information in Item 7.01 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act unless specifically incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 17, 2026) for the specific details of the announcement.
- Verify if the press release has been incorporated by reference into other filings to determine liability under Section 18 of the Exchange Act.
- Check subsequent filings (10-K or 10-Q) for updated financial metrics if the press release pertains to financial performance.